期刊文献+

肠易激综合症药物治疗的研究进展 被引量:21

下载PDF
导出
摘要 肠易激综合症(I耐tablebowelsyndrome,IBS)是一种常见的慢性胃肠道疾病,以腹痛、腹部不适和排便习惯改变为主要特征,常持续存在或反复发作,经检查可以排除引起这些症状的器质性疾病,目前认为本病是一种功能性肠道疾病。在西方国家IBS发病率为10%-15%,而在中国由于地域,人种不同,各地发病率有所不同,北京地区的发病率为0.82%,
出处 《西南军医》 2012年第1期134-137,共4页 Journal of Military Surgeon in Southwest China
  • 相关文献

参考文献22

  • 1Torpy JM,Golub RM.JAMA patient page.Irritable bowel syndrome[J].JAMA 2011;306(13):1501.
  • 2Ljotsson B,Andersson G,Andersson E et al.Acceptability,effec-tiveness,and cost-effectiveness of internet-based exposure treat-ment for irritable bowel syndrome in a clinical sample:a randomizedcontrolled trial[J].BMC Gastroenterol 2011,11(1):110.
  • 3Philip Hilgard,Alisan Kahraman,Nils Lehmann,Cornelia Seltmann,Susanne Beckebaum,R Stefan Ross,Hideo A Baba,Massimo Malago,Christoph E Broelsch,Guido Gerken.Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation:Effects on virus replication and recurrent hepatitis[J].World Journal of Gastroenterology,2006,12(5):697-702. 被引量:236
  • 4Spiller RC.Targeting the 5-HT(3)receptor in the treatment of irri-table bowel syndrome[J].Curr Opin Pharmacol 2011,11(1):68-74.
  • 5Kanazawa M,Watanabe S,Tana C et al.Effect of 5-HT4 receptoragonist mosapride citrate on rectosigmoid sensorimotor function in pa-tients with irritable bowel syndrome[J].Neurogastroenterol Motil,2011,23(8):754-e332.
  • 6Krause R,Ameen V,Gordon SH et al.A randomized,double-blind,placebo-controlled study to assess efficacy and safety of 0.5mg and 1 mg alosetron in women with severe diarrhea-predominantIBS[J].Am J Gastroenterol,2007,102(8):1709-1719.
  • 7Evans BW,Clark WK,Moore DJ et al.Tegaserod for the treatment ofirritable bowel syndrome and chronic constipation[J].Cochrane Data-base Syst Rev 2007(4):CD003960.
  • 8Evans BW,Clark WK,Moore DJ et al.Tegaserod for the treatment ofirritable bowel syndrome[J].Cochrane Database Syst Rev,2004(1):CD003960.
  • 9Lunsford TN,Harris LA.Lubiprostone:evaluation of the newestmedication for the treatment of adult women with constipation-pre-dominant irritable bowel syndrome[J].Int J Womens Health,2010,2:361-374.
  • 10Fukudo S,Hongo M,Kaneko H et al.Efficacy and safety of oral lu-biprostone in constipated patients with or without irritable bowel syn-drome:a randomized,placebo-controlled and dose-finding study[J].Neurogastroenterol Motil,2011,23(6):544-e205.

二级参考文献32

  • 1[1]Lauer GM,Walker BD.Hepatitis C virus infection.N Engl J Med 2001; 345:41-52.
  • 2[2]Alter MJ,Kruszon-Moran D,Nainan OV,McQuillan GM,Gao F,Moyer LA,Kaslow RA,Margolis HS.The prevalence of hepatitis C virus infection in the United States,1988 through 1994.N Engl J Med 1999; 341:556-562
  • 3[3]Curry MP.Hepatitis B and hepatitis C viruses in liver transplantation.Transplantation 2004; 78:955-963
  • 4[4]Vargas HE,Laskus T,Radkowski M,Wilkinson J,Balan V,Douglas DD,Harrison ME,Mulligan DC,Olden K,Adair D,Rakela J.Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.Liver Transpl 2002; 8:1014-1019
  • 5[5]Yan FM,Chen AS,Hao F,Zhao XP,Gu CH,Zhao LB,Yang DL,Hao LJ.Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C.World J Gastroenterol 2000; 6:805-811
  • 6[6]Lamelin JP,Zoulim F,Trepo C.Lymphotropism of hepatitis B and C viruses:an update and a newcomer.Int J Clin Lab Res 1995; 25:1-6
  • 7[7]Gruener NH,Jung MC,Schirren CA.Recurrent hepatitis C virus infection after liver transplantation:natural course,therapeutic approach and possible mechanisms of viral control.J Antimicrob Chemother 2004; 54:17-20
  • 8[8]Porter SB,Reddy KR.Factors that influence the severity of recurrent hepatitis C virus following liver transplantation.Clin Liver Dis 2003; 7:603-614
  • 9[9]Prieto M,Berenguer M,Rayon JM,Cordoba J,Arguello L,Carrasco D,Garcia-Herola A,Olaso V,De Juan M,Gobernado M,Mir J,Berenguer J.High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation:relationship with rejection episodes.Hepatology 1999; 29:250-256
  • 10[10]Forman LM,Lewis JD,Berlin JA,Feldman HI,Lucey MR.The association between hepatitis C infection and survival after orthotopic liver transplantation.Gastroenterology 2002; 122:889-896

共引文献235

同被引文献156

引证文献21

二级引证文献106

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部